Track topics on Twitter Track topics that are important to you
Nokia Corporation Stock Exchange Release July 28, 2016 at 9:00 (CET +1)
ESPOO, Finland, July 28, 2016 (GLOBE NEWSWIRE) --Nokia will publish its second quarter 2016 and January-June 2016 interim report on August 4, 2016 at approximately 8 a.m. Finnish time (CET+1). The interim report will be made available on the Nokia website immediately after publication.
Nokia only publishes a summary of its interim reports in stock exchange releases. The summary focuses on Nokia Group's financial information as well as on Nokia's outlook.
The detailed segment level discussion will be available in the complete second quarter 2016 and January-June 2016 interim report available at http://company.nokia.com/financials. Investors should not solely rely on summaries of Nokia's reports, but should also review the complete reports with tables.
Nokia's analyst conference call will begin on August 4 at 3 p.m. Finnish time. A link to the webcast of the conference call will be available at http://company.nokia.com/financials. Media representatives can listen in via the link on that website, or alternatively call +1 706 634 5012, conference ID: 51880941.
Nokia is a global leader in the technologies that connect people and things. Powered by the innovation of Nokia Bell Labs and Nokia Technologies, the company is at the forefront of creating and licensing the technologies that are increasingly at the heart of our connected lives.
With state-of-the-art software, hardware and services for any type of network, Nokia is uniquely positioned to help communication service providers, governments, and large enterprises deliver on the promise of 5G, the Cloud and the Internet of Things. http://www.nokia.com
Tel. +358 (0) 10 448 4900
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Cardiology is a specialty of internal medicine. Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...